Phase IV Study of Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia.
Phase of Trial: Phase IV
Latest Information Update: 09 Jun 2013
At a glance
- Drugs Ramelteon (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Adverse reactions
- 29 Sep 2010 Actual end date changed from Oct 2009 to March 2010 as reported by ClinicalTrials.gov.
- 07 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Aug 2009 Planned end date changed from 1 Jun 2009 to 1 Oct 2009 as reported by ClinicalTrials.gov.